Both copyright and copyright represent a class of drugs called GLP-1 GLP-1 agonists . These powerful treatments operate by mimicking the body's natural substance, GLP-1 , to help lower blood sugar and promote weight reduction . This shared mechanism of function explains why these treatments are frequently considered together and represent a crucial

Individuals struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. T